Blackstone to Buy BioMed Realty in $8 Billion Transaction

BioMed Realty Trust, Inc. (NYSE: BMR) said Oct. 8 that private equity firm Blackstone Group L.P. has agreed to acquire the life sciences office and lab space REIT in an all-cash transaction valued at $ 8 billion.

Blackstone’s real estate arm, Blackstone Real Estate Partners VIII, will pay $ 23.75 for each outstanding BioMed common share. This represents a premium of about 24 percent above the closing stock price on Sept. 22, the last date before speculation began about a potential sale of the company.

News

Fidelity Portfolio Manager Expects Active REIT Transaction Market in 2015

Steve Buller, portfolio manager at Fidelity Investments, joined REIT.com for a video interview at REITWorld 2014: NAREIT’s Annual Convention for All Things REIT at the Atlanta Marriott Marquis.

Buller discussed the impact of rising interest rates on REITs in both the United States and abroad.  He noted that on a historical basis, there has been little correlation between REIT returns and higher interest rates.

News